US Patent Litigations are now available. Check here

Explore detailed information on the case number ACT_59173/2024 involving Amgen Switzerland Ag Vilniaus Filialas and Alexion Pharmaceuticals. Get insights into the proceedings, key dates, and all parties involved. Stay informed with the latest updates from IP Verse.

Case Details

Case Number:ACT_59173/2024
Patent Number:EP3167888
Case Filing Date:31 Oct, 2024
Proceeding Type:Proceeding
Action/Application:Revocation Action
Court Division:First Instance, Central Division - Milan
Language of Proceeding:English
Plaintiffs:

Amgen Switzerland Ag Vilniaus Filialas

Defendants:

Alexion Pharmaceuticals

Judges:

Marije Knijff

Rudi Goedeweeck

andrea postiglione

Case Decision

No decision available

More cases on

Case Number:ACT_13849/2024
Plaintiffs:

Alexion Pharmaceuticals

Defendants:

Samsung Bioepis Nl B.V.

Case Number:ACT_13886/2024
Plaintiffs:

Alexion Pharmaceuticals

Defendants:

Amgen N.V.

Amgen Biofarmaceutica Lda.

Amgen Gmbh

Amgen S.A.S.

Amgen Zdravila D.O.O.

Amgen Technology (Ireland) Unlimited Company

Amgen Ab

Amgen S.R.L.

Case Number:APL_40470/2024
Plaintiffs:

Alexion Pharmaceuticals

Defendants:

Samsung Bioepis Nl B.V.

Case Number:APL_40553/2024
Plaintiffs:

Alexion Pharmaceuticals

Defendants:

Amgen Technology (Ireland) Unlimited Company

Amgen N.V.

Amgen Gmbh

Amgen Ab

Amgen S.A.S.

Amgen S.R.L.

Amgen Biofarmaceutica Lda.

Amgen Zdravila D.O.O.

More cases on Amgen Switzerland Ag Vilniaus Filialas

No results found

More cases on Alexion Pharmaceuticals

No results found